September 2023

The Download: stem cell experiments, and coining “embryo tech”

September 1, 2023
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. A biotech company says it put dopamine-making cells into people’s brains The news: In an important test for stem-cell medicine, biotech company BlueRock Therapeutics says implants of lab-made neurons introduced into the brains…

Korean internet giant Naver explores robotics, AI and autonomous driving

September 1, 2023
In July last year, Naver, maker of the search engine known as the “Google of South Korea,” opened its new second headquarters, Naver 1784. The building’s name refers to a year commonly associated with the Industrial Revolution. Inside you’ll find a testament to automation’s growing global influence, in the form of 100 autonomous robots.  The robots, […]

How the FBI took down the notorious Qakbot botnet

September 1, 2023
A global law enforcement operation this week took down and dismantled the notorious Qakbot botnet, touted as the largest U.S.-led financial and technical disruption of a botnet infrastructure. Qakbot is a banking trojan that became infamous for providing an initial foothold on a victim’s network for other hackers to buy access and deliver their own […]

Google pulls popular but controversial live video chat app Chamet from the Play Store

September 1, 2023
Google has removed a popular but controversial live video chat app Chamet from the Play Store. The company confirmed the move to TechCrunch saying that the app violated its user-generated content (UGC) policy. The company didn’t provide a statement but pointed to its policy which says, “Apps whose primary purpose is featuring objectionable UGC will […]

Here’s why I am coining the term “embryo tech”

September 1, 2023
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. This week, I published a story about the results of a study on Parkinson’s disease in which a biotech company transplanted dopamine-making neurons into people’s brains.…